Strategic marketing for B2B technology companies and established traditional businesses. Voice and approach adapt to the industry. The commitment to fixed-scope, fixed-price work does not.
Built for VPs of Marketing, Heads of Growth, CMOs, and CEOs without a CMO. Applies to growth-stage technology companies and established traditional businesses at $5M-$250M revenue.
SF Marketing Agency works with ten industries across two distinct client profiles: growth-stage B2B technology companies (AI, SaaS, fintech, PE-backed) and established traditional businesses (construction, legal, healthcare, manufacturing, financial services, real estate). Each industry receives a strategy built for its buying environment, not adapted from a generic playbook.
The vertical matters because the buying committee, risk language, proof standard, sales cycle, and trigger event change by category. The strategy has to reflect that reality before channels or creative are chosen.
The page identifies the real decision participants: economic buyer, evaluator, champion, operator, or referral source.
Every market has a different perceived risk: budget waste, operational failure, compliance exposure, partner credibility, or reputation.
The strategy defines which proof the buyer needs before action: numbers, process, clinical depth, technical capability, or commercial outcomes.
The page routes into the right first engagement instead of forcing a generic service conversation.
Two client profiles. Two distinct strategic voices. One consistent methodology: fixed-scope diagnostics, written strategy documents, and execution architecture your team can run from.
Category creation, enterprise evaluator trust, and pricing under capability uncertainty. The GTM motion for AI has its own commercial physics.
Read →Demand generation, ICP refinement, and positioning for Series A through Series C SaaS companies with a defined product and a crowded market.
Read →GTM strategy for regulated financial technology companies. Trust architecture, compliance-aware positioning, and channel strategy for financial buyers.
Read →Marketing strategy built around portfolio timelines, EBITDA sensitivity, and the commercial objectives of a PE hold period rather than venture growth metrics.
Read →Marketing for commercial construction firms, general contractors, and specialty subcontractors competing for complex B2B project work.
Read →Business development and marketing strategy for law firms and legal practices where referral networks intersect with modern client acquisition.
Read →Patient acquisition, physician referral development, and brand positioning for healthcare organizations and medical practices.
Read →Commercial marketing for industrial manufacturers, including channel strategy, distributor enablement, and OEM market positioning.
Read →Marketing strategy for wealth management firms, RIAs, and financial advisory practices. Compliance-aware, trust-led positioning.
Read →Marketing for commercial real estate firms, developers, and brokerages where project pipeline and institutional relationships drive growth.
Read →Patient acquisition economics for multi-location DSO, MSO, dermatology, orthodontic, optometry, and specialty practice operators.
Read →The strategic methodology is consistent across all ten industries: a fixed-scope diagnostic, a written strategy document covering positioning, go-to-market, and demand generation, and a clear path to execution. What changes is the language, the benchmarks, and the commercial context.
Tech companies get directness and metrics language. Traditional businesses get institutional precision. Neither gets marketing-speak.
Voice A serves technology companies. Buyers in this segment respond to direct, outcome-specific language, financial metrics, and competitive clarity. Voice B serves established traditional businesses. Buyers in these categories respond to institutional credibility, industry-specific depth, and proof over claims. Both voices operate under the same constraint: every sentence either advances the commercial case or it does not belong in the document.
For AI companies, B2B SaaS, fintech, and PE-backed companies.
For construction, legal, healthcare, manufacturing, financial services, and real estate.
Five fixed-scope entry points from $2,500. Every engagement starts with a diagnostic - not a retainer, not a vague strategy conversation. A scoped document with a defined deliverable and a fixed price.